Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study
Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Background:
Omalizumab may modulate airway remodeling in severe asthma. Using forced expiratory volume in 1 second (FEV1) as a surrogate of airway remodeling, we aimed to investigate if an omalizumab add-on in severe allergic asthma may lead to a persistent reversal of airway obstruction and to evaluate the potential biomarkers of airway obstruc...
Alternative Titles
Full title
Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_61d701a11621428fa03ee819e43d5c8b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_61d701a11621428fa03ee819e43d5c8b
Other Identifiers
ISSN
1753-4666,1753-4658
E-ISSN
1753-4666
DOI
10.1177/1753466619841274
